Skip to content
Ask LynxScribe
LynxScribe
Start new conversation

Accelerate the discovery and development of new drugs using AI

Harness cutting-edge AI, Generative AI, and graph analytics to shorten timelines, reduce costs, and improve decision-making across the R&D pipeline.

 

R&D-hero-banner-mobile-1242x2208

In drug discovery and clinical development, every day counts. AI can help you move from data to decision faster—whether you’re predicting the shape of a target protein, designing novel molecules, checking for IP conflicts, or selecting the right participants for clinical trials. Lynx Analytics combines advanced AI modeling with deep domain expertise to help Life Sciences R&D teams bring new therapies to patients sooner.

3d proteins illustration

Build 3D models for target proteins

Predict the structure and function of potential drug targets faster and more accurately.

protein folding

Leverage AI-powered protein folding prediction to reduce lab time

computational data
Identify binding sites for more precise drug design
drug design
Integrate experimental and computational data into a single, interactive model
3d proteins illustration
Test 2

Generate and screen possible drug compounds

Rapidly explore vast chemical spaces to find the most promising candidates.

design novel molecules

Use Generative AI to design novel molecules that fit your target profile

simulate binding affinity

Simulate binding affinity and pharmacokinetics before synthesis

prioritize compounds

Prioritize compounds with the highest likelihood of success for wet lab testing

drug viability illustration

Assess drug viability and mechanisms 

De-risk candidates early by predicting their biological behavior and impact.

ADME

Forecast a drug's journey through the body by modeling ADME (Absorption, Distribution, Metabolism, and Excretion) properties

flag safety issues
Run in silico toxicology models to flag potential safety issues and off-target effects before live testing.
BioKnowledge Graphs

Build BioKnowledge Graphs to map the complex pathways connecting genes, proteins, and diseases.

syringe-solid

Uncover the mechanisms behind side effects and identify new opportunities for treatment

drug viability illustration
biomedical literature illustration
biomedical literature illustration

Mine biomedical literature for
hidden insights

Turn the constant stream of scientific publications into a strategic advantage.

NLP scanning
Use AI-powered natural language processing (NLP) to scan millions of research articles, patents, and clinical trial records
detect trends
Detect emerging trends, repurposing opportunities, and early safety signals
bio data extraction

Automatically extract relationships between genes, diseases, biomarkers, and therapeutic approaches

dynamic graphs
Build dynamic, searchable knowledge graphs from unstructured text to fuel hypothesis generation and faster decision-making
freedom to operate illustration

Check for freedom to operate (FT0)

Mitigate risk by identifying potential IP conflicts early.

screen global patent database

Screen against global patent databases using AI-driven semantic search

save costly delays
Save costly delays by ensuring clear paths to market from the start
freedom to operate illustration

Talk to us

AI is no longer a future vision—it’s a competitive advantage today. Let us show you how Lynx Analytics can help your R&D team reduce discovery time, de-risk clinical trials, and accelerate your path to approval.